SCHEMBL7079542

SCHEMBL7079542

O=C(Nc1ccc(Cl)cc1)n1ccc(/C=C/c2cccs2)n1.O=C(c1ccc(Cl)cc1)n1ccc(C(c2ccccc2)c2ccccc2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 3/20 0.37
▸ PLAU P00749 2/20 0.37
▸ F2 P00734 1/20 0.37
▸ KLKB1 P03952 1/20 0.37
▸ KMT2A Q03164 7/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ RAB9A P51151 5/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ NPSR1 Q6W5P4 3/20 0.35
▸ LMNA P02545 6/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ MEN1 O00255 5/20 0.33
▸ MAPT P10636 5/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HTT P42858 2/20 0.33
▸ THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7079546 1.00 ELANE (0.37) ELANEPLAUF2KLKB1KMT2A
SCHEMBL1224684 0.84 LMNA (0.45) KMT2ATDP1RAB9AALDH1A1NPSR1
SCHEMBL1224685 0.84 LMNA (0.45) KMT2ATDP1RAB9AALDH1A1NPSR1
SCHEMBL1225255 0.82 KMT2A (0.45) ELANEPLAUKMT2AL3MBTL1TDP1
SCHEMBL1225252 0.82 KMT2A (0.45) ELANEPLAUKMT2AL3MBTL1TDP1
SCHEMBL1225817 0.80 RAB9A (0.48) KMT2ATDP1RAB9AALDH1A1NPSR1
SCHEMBL1225818 0.80 RAB9A (0.48) KMT2ATDP1RAB9AALDH1A1NPSR1
SCHEMBL1225298 0.78 F2 (0.44) ELANEPLAUF2KLKB1KMT2A
SCHEMBL2162205 0.76 KMT2A (0.58) ELANEPLAUF2KLKB1KMT2A
SCHEMBL2162202 0.76 KMT2A (0.58) ELANEPLAUF2KLKB1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6589997-B2 1-Phenylprop-2-en-1-one derivatives as wound healing, anticarcinogenic, antiarthritic, antitumor, antiproliferative, antiinflammatory or antimetastasis agents NORTH SHORE-LONG ISLAND JEWISH HEALTH SYSTEM 2003-07-08 — — US disclosed
US-20030045559-A1 Small-molecule modulators of hepatocyte growth factor / scatter factor activities NORTH SHORE-LONG ISLAND JEWISH HEALTH SYSTEM 2003-03-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030045559-A1 Small-molecule modulators of hepatocyte growth factor / scatter factor activities HGF, HDGF, MET ELANE 1810/4885PLAU 1052/4885F2 466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback